Skip to main content

Table 3 Summary of the averages (± SD) of parameters and basic results of the biokinetics study after [105Ag]AgNP inhalation

From: Quantitative biokinetics over a 28 day period of freshly generated, pristine, 20 nm silver nanoparticle aerosols in healthy adult rats after a single 1½-hour inhalation exposure

Time-point after inhalation

0.75 h(1st)

0.75 h(2nd)

4 h

24 h(1st)

24 h(2nd)

7d

28d

Inhaled aerosol volume (L)1

37 ± 27

36 ± 27

36 ± 27

35 ± 26

37 ± 28

40 ± 30

40 ± 30

Inhaled [105Ag]AgNP activity (kBq)1

124.7 ± 3.3

101 ± 3.1

135.3 ± 7.8

118.3 ± 2

97.9 ± 5.7

112.7 ± 4.8

88.7 ± 3.5

Deposited[105Ag]AgNP activity (kBq)1

31.4 ± 9.6

29.6 ± 8.4

37.8 ± 7.1

38.7 ± 4.91

36.1 ± 8.86

34.2 ± 13.9

37.9 ± 13.6

Deposited AgNP mass (μg)1

12.1 ± 3.7

11.4 ± 3.2

14.6 ± 2.7

14.9 ± 1.9

13.9 ± 3.4

13.2 ± 5.3

14.6 ± 5.3

Deposited number of AgNP (# •1011)

5.78 ± 1.77

6.63 ± 1.89

5.59 ± 1.04

7.13 ± 0.91

8.45 ± 2.08

11.32 ± 4.59

10.82 ± 3.91

Deposited fraction (inhaled)1

0.25 ± 0.08

0.29 ± 0.09

0.28 ± 0.06

0.33 ± 0.04

0.37 ± 0.09

0.30 ± 0.11

0.43 ± 0.16

Retained alveolar [105Ag]AgNP fraction (/ILD) at dissection1

0.90 ± 0.02

0.88 ± 0.05

0.69 ± 0.01

0.55 ± 0.03

0.62 ± 0.05

0.14 ± 0.09

0.041 ± 0.02

Fast early cleared fraction (/ILD)1

0.07 ± 0.01

0.09 ± 0.04

0.27 ± 0.01

0.36 ± 0.03

0.30 ± 0.02

0.60 ± 0.12

0.57 ± 0.04

Slow long-term cleared fraction (/ILD)1

     

0.25 ± 0.03

0.35 ± 0.05

  1. 1 according to Eqns. 1–8, 10–16 of Supplementary Information
  2. Parameters of the intratracheal inhaled [105Ag]AgNP aerosol inhalation and deposition for each group of rats: inhaled aerosol volume and 105Ag activity, deposited 105Ag activity and the corresponding deposited [105Ag]AgNP mass and NP number, deposited 105Ag activity as a fraction of the inhaled 105Ag activity. Additionally, the retained alveolar fraction at the time of dissection, the early clearance during the first two days p.e. and the integral long-term clearance of [105Ag]AgNP including their secondary products from day 3–28 after inhalation is given; the latter is calculated based on fecal excretion and retention in the gastro-intestinal-tract (GIT). All fractional data are normalized to the Initial Lung Dose (ILD), i.e. the sum of 105Ag radioactivities of all organs and tissues including excretion